News Releases

Young Patients See Strength in Numbers at Moffitt’s Pediatric Melanoma Clinic Day

Despite Treatment, Elderly Cancer Patients Have Worse Outcomes if HIV-Positive

New study investigates disparity in cancer-related mortality among patients 65 or older with and without HIV

Moffitt Once Again a Top 10 Cancer Hospital Based on U.S. News World Report

The national rankings, released today, also place Moffitt as the top cancer hospital in Florida

Moffitt Research of Selinexor for Relapsed/Refractory Multiple Myeloma Facilitates Recent FDA Approval

Studies to expand its use in other cancers are ongoing at Moffitt Cancer Center

Moffitt Offers Free Cancer Screenings July 27 at Clearwater Beach’s Pier 60

Robert Rothman Joins Moffitt’s National Board of Advisors

Tampa Bay Mascots Motivate Patients with a Flash Mob at Moffitt Cancer Center

Moffitt Cancer Center’s Healthy KIDZ Program to Give Local Students Dose of Health Care Experience

Therapeutic Strategies Based on Evolutionary Principles May Be Key to Improving Patient Outcomes

Moffitt Researchers Identify Effective Drug Combination Against Uveal Melanoma in Preclinical Studies

The subtypes have different genetic, chromosomal and protein alterations that could present therapeutic opportunities

Work-Life Balance, Career Development and Mission Keep Moffitt Cancer Center on Computerworld’s List of 100 Best Places to Work in IT

Computerworld magazine recently ranked Moffitt as 31 on its list of top 100 Best Places to Work in IT 2019.

Moffitt Cancer Center Partners with TuHURA Biopharma Inc. to Develop a New Generation of Targeted Immunotherapies

This agreement will provide TuHURA the exclusive rights to develop Moffitt's first-in-class bifunctional immunoconjugates that are cancer cell...

Moffitt Cancer Center Joins Forces with AdventHealth to Expand Cancer Care in the Tampa Bay Region

The new Moffitt outpatient center at AdventHealth Wesley Chapel will provide medical and radiation oncology services and is designed to accommodate...

Researchers Pinpoint Why Lymphoma Patients May Become Resistant to Specific Therapy, Identify Strategy to Overcome It

Loss of the BCL-2 amplicon and transcriptional reprogramming contribute to resistance to the drug Venetoclax® for those with B-cell lymphomas

Moffitt Cancer Center’s Healthy KIDZ Program To Award $24,000 in Scholarships to High School Seniors

Mayor Elect Jane Castor, Hillsborough County Superintendent Jeff Eakins, Hillsborough County Sheriff Chad Chronister, NBA referee Lauren Holtkamp and...